Isodiol International Inc. Increases Size of Non-Brokered Offering and Retains Clarus Securities as Financial Advisor
Isodiol International Inc. Announces the Launch of 3 New Cannabidiol (CBD) Product Categories with Level Brands Inc.
Amplia Therapeutics Reports Four Additional Complete Responses and Improved Overall Survival Data in Accent Pancreatic Cancer Trial